GNFTGenfit S.A.

GNFT Stock Price, Valuation & Chart | Genfit S.A.

Compare

$8.950+0.35 (+4.07%)

At close · 09 Mar 2026, 01:30 pm

Sector: Healthcare Industry: Biotechnology GNFT intrinsic value GNFT calculated fair value vs price

Overview Financials Dividends Ratios

GNFT Historical price chart

GNFT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization445.68M

PE Ratio-9.94

EPS-0.9

Trading Volume4.21K

Today's High/Low9.0/8.85

Dividend Yield0.00

52 Week High/Low10.0/2.55

Shares Outstanding49.80M

GNFT Financial Statement

GNFT Analyst ratings

GNFT Analysis & performance metrics

GNFT Company profile

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products…

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH)…

GNFT Management team

Name

Position

Jean-Francois Mouney

Co-Founder & Chairman of the Board

M. Pascal PrigentCEO

Chief Executive Officer

Laurent LannooCTO

Corporate Secretary & Director of Legal Affairs

Bart Staels

Co-Founder & Chairman of the Scientific Advisory Board

Thomas BaetzCFO

Chief Financial Officer

Dean W. Hum Ph.D.

Chief Scientific Officer

Pascal CaiseyCOO

Chief Operating Officer

Stefanie Magner J.D.

Chief Compliance Officer & Executive Vice President of International Legal Affairs

Name

Position

Jean-Francois Mouney

Co-Founder & Chairman of the Board

M. Pascal PrigentCEO

Chief Executive Officer

Laurent LannooCTO

Corporate Secretary & Director of Legal Affairs

Bart Staels

Co-Founder & Chairman of the Scientific Advisory Board

Thomas BaetzCFO

Chief Financial Officer

Dean W. Hum Ph.D.

Chief Scientific Officer

Pascal CaiseyCOO

Chief Operating Officer

Stefanie Magner J.D.

Chief Compliance Officer & Executive Vice President of International Legal Affairs

Management Team

Jean-Francois Mouney

Co-Founder & Chairman of the Board

M. Pascal PrigentCEO

Chief Executive Officer

Laurent LannooCTO

Corporate Secretary & Director of Legal Affairs

Bart Staels

Co-Founder & Chairman of the Scientific Advisory Board

Thomas BaetzCFO

Chief Financial Officer

Dean W. Hum Ph.D.

Chief Scientific Officer

Pascal CaiseyCOO

Chief Operating Officer

Stefanie Magner J.D.

Chief Compliance Officer & Executive Vice President of International Legal Affairs

Management

Jean-Francois Mouney

Co-Founder & Chairman of the Board

M. Pascal PrigentCEO

Chief Executive Officer

Laurent LannooCTO

Corporate Secretary & Director of Legal Affairs

Bart Staels

Co-Founder & Chairman of the Scientific Advisory Board

Thomas BaetzCFO

Chief Financial Officer

Dean W. Hum Ph.D.

Chief Scientific Officer

Pascal CaiseyCOO

Chief Operating Officer

Stefanie Magner J.D.

Chief Compliance Officer & Executive Vice President of International Legal Affairs

Total 8 executives

GNFT Frequently asked questions

What is Genfit S.A. (GNFT) Stock Price?

Current stock price of Genfit S.A. (GNFT) stock is $8.950. The stock price is +4.07% higher in the session. The intraday range can be seen from this page. Volume of Genfit S.A. (GNFT) stock is 4.21K.

Last updated at 09 Mar 2026, 01:30 pm.

Why is the Genfit S.A. (GNFT) stock price going up or down today?

The stock price of Genfit S.A. (GNFT) can change with earnings, company news, and overall market sentiment. Genfit S.A. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Genfit S.A. stock expensive at its current price?

Whether Genfit S.A. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GNFT on this page is -9.94. EPS on this page is -0.90. Compare those figures with peers and growth expectations before deciding if the current Genfit S.A. price is justified.

How has the stock price of Genfit S.A. (GNFT) performed historically?

Historical performance for Genfit S.A. (GNFT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GNFT reacted to past earnings and market events.

Should I buy Genfit S.A. (GNFT) stock, at this price?

Buying Genfit S.A. (GNFT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.